Literature DB >> 18554181

Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17.

Jens F Rehfeld1, Xiaorong Zhu, Christina Norrbom, Jens R Bundgaard, Anders H Johnsen, John E Nielsen, Jonas Vikesaa, Jeffrey Stein, Arunangsu Dey, Donald F Steiner, Lennart Friis-Hansen.   

Abstract

Cellular synthesis of peptide hormones requires PCs (prohormone convertases) for the endoproteolysis of prohormones. Antral G-cells synthesize the most gastrin and express PC1/3, 2 and 5/6 in the rat and human. But the cleavage sites in progastrin for each PC have not been determined. Therefore, in the present study, we measured the concentrations of progastrin, processing intermediates and alpha-amidated gastrins in antral extracts from PC1/3-null mice and compared the results with those in mice lacking PC2 and wild-type controls. The expression of PCs was examined by immunocytochemistry and in situ hybridization of mouse G-cells. Finally, the in vitro effect of recombinant PC5/6 on progastrin and progastrin fragments containing the relevant dibasic cleavage sites was also examined. The results showed that mouse G-cells express PC1/3, 2 and 5/6. The concentration of progastrin in PC1/3-null mice was elevated 3-fold. Chromatography showed that cleavage of the Arg(36)Arg(37) and Arg(73)Arg(74) sites were grossly decreased. Accordingly, the concentrations of progastrin products were markedly reduced, alpha-amidated gastrins (-34 and -17) being 25% of normal. Lack of PC1/3 was without effect on the third dibasic site (Lys(53)Lys(54)), which is the only processing site for PC2. Recombinant PC5/6 did not cleave any of the dibasic processing sites in progastrin and fragments containing the relevant dibasic processing sites. The complementary cleavages of PC1/3 and 2, however, suffice to explain most of the normal endoproteolysis of progastrin. Moreover, the results show that PCs react differently to the same dibasic sequences, suggesting that additional structural factors modulate the substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554181     DOI: 10.1042/BJ20080881

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

Review 1.  Role of gastrin-peptides in Barrett's and colorectal carcinogenesis.

Authors:  Eduardo Chueca; Angel Lanas; Elena Piazuelo
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

2.  Juvenile polyposis of the stomach--a novel cause of hypergastrinemia.

Authors:  Karen D Papay; Vincent G Falck; Steen S Poulsen; Remo Panaccione; Jens F Rehfeld; Martin A Storr
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-31       Impact factor: 46.802

Review 3.  Peptide processing and biology in human disease.

Authors:  Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

Review 4.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

Review 5.  Parasite neuropeptide biology: Seeding rational drug target selection?

Authors:  Paul McVeigh; Louise Atkinson; Nikki J Marks; Angela Mousley; Johnathan J Dalzell; Ann Sluder; Lance Hammerland; Aaron G Maule
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-15       Impact factor: 4.077

6.  Genetics of the first seven proprotein convertase enzymes in health and disease.

Authors:  Hannu Turpeinen; Zsuzsanna Ortutay; Marko Pesu
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

7.  The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.

Authors:  Benoit You; Frédéric Mercier; Eric Assenat; Carole Langlois-Jacques; Olivier Glehen; Julien Soulé; Léa Payen; Vahan Kepenekian; Marie Dupuy; Fanny Belouin; Eric Morency; Véronique Saywell; Maud Flacelière; Philippe Elies; Pierre Liaud; Thibault Mazard; Delphine Maucort-Boulch; Winston Tan; Bérengère Vire; Laurent Villeneuve; Marc Ychou; Manish Kohli; Dominique Joubert; Alexandre Prieur
Journal:  EBioMedicine       Date:  2019-12-24       Impact factor: 8.143

8.  Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma.

Authors:  Manish Kohli; Winston Tan; Bérengère Vire; Pierre Liaud; Mélina Blairvacq; Frederic Berthier; Daniel Rouison; George Garnier; Léa Payen; Thierry Cousin; Dominique Joubert; Alexandre Prieur
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

Review 9.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.

Authors:  Marie Dupuy; Sarah Iltache; Benjamin Rivière; Alexandre Prieur; George Philippe Pageaux; José Ursic Bedoya; Stéphanie Faure; Heloïse Guillaumée; Eric Assenat
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.